Old Web
English
Sign In
Acemap
>
authorDetail
>
David Borquez
David Borquez
Medicine
Breast cancer
Immunology
Doxorubicin
Paclitaxel
5
Papers
85
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pilot trial of trastuzumab starting with or after the doxorubicin component of a doxorubicin plus paclitaxel regimen for women with HER2-positive advanced breast cancer.
2003
Clinical Cancer Research
Giulia Valeria Bianchi
John Albanell
W. Eiermann
Giordano Vitali
David Borquez
Lucia Viganò
R. Molina
Günter Raab
Alberta Locatelli
Bart Vanhauwere
Luca Gianni
José Baselga
Show All
Source
Cite
Save
Citations (52)
Cardiac safety and antitumor activity of doxorubicin and taxol followed by weekly taxol (AT&T) when herceptin is initiated with AT or with T alone in women with HER2-positive advanced breast cancer
2001
European Journal of Cancer
Luca Gianni
W. Eiermann
David Borquez
Joan Albanell
R. Molina
Bart Vanhauwere
J. Baselga
Show All
Source
Cite
Save
Citations (5)
Survival of Tumor Cells in Stem Cell Preparations and Bone Marrow of Patients with High-Risk or Metastatic Breast Cancer after Receiving Dose-intensive or High-Dose Chemotherapy
2001
Clinical Cancer Research
Sabine Kasimir-Bauer
Susanne Mayer
P. Bojko
David Borquez
Rainer Neumann
S. Seeber
Show All
Source
Cite
Save
Citations (28)
Band 22, Supplement 2, Oktober 1999
1999
Onkologie
W. Jonat
F. Jänicke
J. Hilfrich
Christian Jackisch
R. Jakesz im Namen der Austrian Breast
W. Eiermann
Holger Eidtmann
Jacobus Pfisterer
Jens-Uwe Blohmer
J. Crown
T. Bauknecht
J. Dunst
David Borquez
S Seeber
Christoph Thomssen
Show All
Source
Cite
Save
Citations (0)
Infusional 5-FU, Folinic Acid, Paclitaxel, and Cisplatin for Metastatic
1997
Ute Klaassen
Hans-Jochen Wilke
Christian D. Muller
David Borquez
Michael Korn
Klaus Diergarten
Siegfried Seeber
Show All
Source
Cite
Save
Citations (0)
1